Clinical Trials for Metastatic Breast Cancer

Find clinical trials for metastatic breast cancer. Discover research opportunities and treatment options in your area.

166 Active Trials Found

Showing 166 trials on this page

Page 8 of 9

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

NCT ID: NCT06308939

This clinical trial is exploring a new treatment approach for women with advanced breast cancer that cannot be surgically removed and is HER2-negative. The study is testing a combination of two med...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China

A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

NCT ID: NCT06202261

This clinical trial is studying a new treatment called TQB2930 for patients with recurrent or metastatic breast cancer, which means the cancer has either come back after treatment or has spread to ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Harbin, Heilongjiang, China, Chongqing, Chongqing, China

Vaccination With Flt3L, Radiation, and Poly-ICLC

NCT ID: NCT03789097

This clinical trial is exploring a new treatment approach for patients with certain types of cancer, including Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, and Head and Neck Squamous Cell Carc...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States

Olaparib Maintenance Therapy in Metastatic Breast Cancer

NCT ID: NCT05629429

This clinical trial is studying the effects of a drug called Olaparib as a maintenance therapy for patients with metastatic breast cancer. Specifically, it aims to find out if Olaparib can help del...

Recruiting

Phase: PHASE2 Type: interventional Locations: Taipei, Please Select, Taiwan, Taipei City, Please Select, Taiwan +1 more

Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype

NCT ID: NCT05954442

This clinical trial is looking at a new treatment approach for women with advanced triple-negative breast cancer (TNBC), specifically those with a subtype known as luminal androgen receptor (LAR) a...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China, Shanghai, Shanghai, China

Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy

NCT ID: NCT06151249

This clinical trial is looking at a new oral solution called Meritup to see if it can help reduce fatigue in women with metastatic breast cancer who are undergoing chemotherapy. Fatigue can be a co...

Not yet recruiting

Phase: PHASE2 Type: interventional

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

NCT ID: NCT06154590

The Anastrozole Adjuvant Trial is studying the effectiveness of a combination treatment of anastrozole and NOLVADEX (tamoxifen citrate) for patients with early breast cancer. The goal is to see if ...

Not yet recruiting

Type: observational Locations: Colorado Springs, Colorado, United States

Metastases Directed Therapy for Oligometastatic Breast Cancer

NCT ID: NCT06144346

This clinical trial is looking at a new treatment approach for women with a specific type of breast cancer known as oligometastatic breast cancer, where the cancer has spread but is limited to a sm...

Recruiting

Phase: NA Type: interventional Locations: Cairo, , Egypt

Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

NCT ID: NCT05804578

This clinical trial is studying a blood test called mDETECT, which aims to help doctors monitor how well treatment is working for women with metastatic breast cancer. Metastatic breast cancer means...

Recruiting

Type: observational Locations: Ottawa, Ontario, Canada, Kingston, Ontario, Canada

Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments

NCT ID: NCT02284581

This clinical trial is looking at how different medical treatments work for patients with metastatic breast cancer (MBC), which is breast cancer that has spread to other parts of the body. The rese...

Recruiting

Type: observational Locations: Rozzano, , Italy, Mantova, , Italy +36 more

Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

NCT ID: NCT04920708

The FAIM trial is studying a new treatment approach for patients with advanced hormone-receptor positive (ER+) and human epidermal growth factor receptor 2 negative (HER2-) breast cancer that has s...

Recruiting

Phase: PHASE2 Type: interventional Locations: London, , United Kingdom, Exeter, , United Kingdom +22 more

The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).

NCT ID: NCT06106711

The clinical trial, known as the EVA study, is looking at how certain treatments for metastatic breast cancer, specifically Antibody-Drug Conjugates (ADCs), affect the quality of life of patients. ...

Not yet recruiting

Type: observational Locations: Milano, , Italy, Aviano, Pordenone, Italy +1 more

Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients

NCT ID: NCT06076772

This clinical trial is designed to study a medication called Palbociclib, which is used to treat metastatic breast cancer that is hormone receptor-positive and HER2 negative. The research aims to u...

Not yet recruiting

Type: observational Locations: Al Madīnah, Al, Saudi Arabia

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

NCT ID: NCT06062498

This clinical trial is designed to compare the effectiveness of a drug called elacestrant alone versus elacestrant combined with another type of medication known as a CDK4/6 inhibitor in treating p...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States

A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer

NCT ID: NCT06023277

This clinical trial is testing a new breast cancer vaccine called ConvitVax for women with metastatic breast cancer, which means the cancer has spread to other parts of the body. The trial aims to ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Pompano Beach, Florida, United States, Caracas, Distrito Capital, Venezuela +1 more

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

NCT ID: NCT04020575

This clinical trial is studying a new treatment for advanced breast cancer that is known to express a specific protein called MUC1*. The treatment involves using a patient’s own immune cells, calle...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences

NCT ID: NCT05760183

This clinical trial is designed to better understand the experiences of patients with metastatic breast cancer who are participating in treatment studies. Researchers want to find out what factors ...

Not yet recruiting

Type: observational

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients

NCT ID: NCT04253561

This clinical trial is exploring the safety and effectiveness of a combination treatment using three medications: ipatasertib, trastuzumab, and pertuzumab. It focuses on patients with advanced brea...

Recruiting

Phase: PHASE1 Type: interventional Locations: Sevilla, , Spain, Madrid, , Spain +10 more

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

NCT ID: NCT05732051

This clinical trial is studying whether a supplement called nicotinamide riboside can help prevent heart problems in women with advanced breast cancer who are receiving a specific type of chemother...

Recruiting

Phase: PHASE2 Type: interventional Locations: Lørenskog, Akershus, Norway

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

NCT ID: NCT05753657

This clinical trial is exploring whether monitoring insulin levels and treating high insulin and blood sugar levels with a medication called pioglitazone can be safe and effective for women with me...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Haifa, , Israel, Haifa, Hatsafon, Israel

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions